Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 100

1.

Subjective responses to oral tobacco products: scale validation.

Hatsukami DK, Zhang Y, O'Connor RJ, Severson HH.

Nicotine Tob Res. 2013 Jul;15(7):1259-64. doi: 10.1093/ntr/nts265. Epub 2012 Dec 13.

PMID:
23239843
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Oral tobacco products: preference and effects among smokers.

Hatsukami DK, Jensen J, Anderson A, Broadbent B, Allen S, Zhang Y, Severson H.

Drug Alcohol Depend. 2011 Nov 1;118(2-3):230-6. doi: 10.1016/j.drugalcdep.2011.03.026. Epub 2011 Apr 23.

PMID:
21515003
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Pilot study on lower nitrosamine smokeless tobacco products compared with medicinal nicotine.

Mendoza-Baumgart MI, Tulunay OE, Hecht SS, Zhang Y, Murphy S, Le C, Jensen J, Hatsukami DK.

Nicotine Tob Res. 2007 Dec;9(12):1309-23.

PMID:
18058349
[PubMed - indexed for MEDLINE]
4.

Changing smokeless tobacco products new tobacco-delivery systems.

Hatsukami DK, Ebbert JO, Feuer RM, Stepanov I, Hecht SS.

Am J Prev Med. 2007 Dec;33(6 Suppl):S368-78. Review.

PMID:
18021912
[PubMed - indexed for MEDLINE]
5.

Evaluating the acute effects of oral, non-combustible potential reduced exposure products marketed to smokers.

Cobb CO, Weaver MF, Eissenberg T.

Tob Control. 2010 Oct;19(5):367-73. doi: 10.1136/tc.2008.028993. Epub 2009 Apr 2.

PMID:
19346218
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Effect of smokeless tobacco product marketing and use on population harm from tobacco use policy perspective for tobacco-risk reduction.

Kozlowski LT.

Am J Prev Med. 2007 Dec;33(6 Suppl):S379-86. Review.

PMID:
18021913
[PubMed - indexed for MEDLINE]
7.

Is snus the same as dip? Smokers' perceptions of new smokeless tobacco advertising.

Bahreinifar S, Sheon NM, Ling PM.

Tob Control. 2013 Mar;22(2):84-90. doi: 10.1136/tobaccocontrol-2011-050022. Epub 2011 Oct 4.

PMID:
21972063
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Effect of oral snus and medicinal nicotine in smokers on toxicant exposure and withdrawal symptoms: a feasibility study.

Kotlyar M, Hertsgaard LA, Lindgren BR, Jensen JA, Carmella SG, Stepanov I, Murphy SE, Hecht SS, Hatsukami DK.

Cancer Epidemiol Biomarkers Prev. 2011 Jan;20(1):91-100. doi: 10.1158/1055-9965.EPI-10-0349. Epub 2010 Nov 10. Erratum in: Cancer Epidemiol Biomarkers Prev. 2011 May;20(5):1048.

PMID:
21068204
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Nicotine delivery, cardiovascular profile, and subjective effects of an oral tobacco product for smokers.

Blank MD, Sams C, Weaver MF, Eissenberg T.

Nicotine Tob Res. 2008 Mar;10(3):417-21. doi: 10.1080/14622200801901880.

PMID:
18324559
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Alternative tobacco product use and smoking cessation: a national study.

Popova L, Ling PM.

Am J Public Health. 2013 May;103(5):923-30. doi: 10.2105/AJPH.2012.301070. Epub 2013 Mar 14.

PMID:
23488521
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Evaluating oral noncombustible potential-reduced exposure products for smokers.

Blank MD, Eissenberg T.

Nicotine Tob Res. 2010 Apr;12(4):336-43. doi: 10.1093/ntr/ntq003. Epub 2010 Feb 16.

PMID:
20159791
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Evaluation of carcinogen exposure in people who used "reduced exposure" tobacco products.

Hatsukami DK, Lemmonds C, Zhang Y, Murphy SE, Le C, Carmella SG, Hecht SS.

J Natl Cancer Inst. 2004 Jun 2;96(11):844-52.

PMID:
15173268
[PubMed - indexed for MEDLINE]
Free Article
13.

The acute effect of Swedish-style snus on cigarette craving and self-administration in male and female smokers.

Barrett SP, Campbell ML, Temporale K, Good KB.

Hum Psychopharmacol. 2011 Jan;26(1):58-62.

PMID:
21305611
[PubMed - indexed for MEDLINE]
14.

Smokers' beliefs about the relative safety of other tobacco products: findings from the ITC collaboration.

O'Connor RJ, McNeill A, Borland R, Hammond D, King B, Boudreau C, Cummings KM.

Nicotine Tob Res. 2007 Oct;9(10):1033-42.

PMID:
17943619
[PubMed - indexed for MEDLINE]
15.

A fresh look at tobacco harm reduction: the case for the electronic cigarette.

Polosa R, Rodu B, Caponnetto P, Maglia M, Raciti C.

Harm Reduct J. 2013 Oct 4;10(1):19. doi: 10.1186/1477-7517-10-19. Review.

PMID:
24090432
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

No sisyphean task: how the FDA can regulate electronic cigarettes.

Paradise J.

Yale J Health Policy Law Ethics. 2013 Summer;13(2):326-74.

PMID:
24340824
[PubMed - indexed for MEDLINE]
17.

Consumer awareness and attitudes related to new potential reduced-exposure tobacco product brands.

Parascandola M, Augustson E, O'Connell ME, Marcus S.

Nicotine Tob Res. 2009 Jul;11(7):886-95. doi: 10.1093/ntr/ntp082. Epub 2009 Jun 18.

PMID:
19541949
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Role of snus in initiation and cessation of tobacco smoking in Sweden.

Ramström LM, Foulds J.

Tob Control. 2006 Jun;15(3):210-4.

PMID:
16728752
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

US smokers' reactions to a brief trial of oral nicotine products.

O'Connor RJ, Norton KJ, Bansal-Travers M, Mahoney MC, Cummings KM, Borland R.

Harm Reduct J. 2011 Jan 10;8(1):1. doi: 10.1186/1477-7517-8-1.

PMID:
21219609
[PubMed]
Free PMC Article
20.

Association between willingness to use snus to quit smoking and perception of relative risk between snus and cigarettes.

Lund KE.

Nicotine Tob Res. 2012 Oct;14(10):1221-8. Epub 2012 Mar 13.

PMID:
22416114
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk